We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

116 hedge funds and large institutions have $303M invested in MaxCyte in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 36

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

2% more funds holding

Funds holding: 114 → 116 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.11% less ownership

Funds ownership: 64.27% → 64.16% (-0.11%)

38% less capital invested

Capital invested by funds: $489M → $303M (-$186M)

78% less call options, than puts

Call options by funds: $5K | Put options by funds: $23K

Holders
116
Holders Change
+2
Holders Change %
+1.75%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
48
Reduced
36
Closed
10
Calls
$5K
Puts
$23K
Net Calls
-$18K
Net Calls Change
-$16K

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
+$5.79M
2
GIM
Granahan Investment Management
Massachusetts
+$5.44M
3
PCM
Portolan Capital Management
Massachusetts
+$4.73M
4
FLAM
First Light Asset Management
Minnesota
+$2.27M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$1.27M

Top Sellers

1
BAMCO Inc
BAMCO Inc
New York
-$9.84M
2
BWLSA
Blue Water Life Science Advisors
California
-$6.16M
3
Millennium Management
Millennium Management
New York
-$4.18M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.49M
5
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$31.8M -$462K -100,577 -1%
VP
2
Vitruvian Partners
United Kingdom
$23.1M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$22.8M +$379K +82,457 +2%
CC
4
Casdin Capital
New York
$21.6M -$965K -210,000 -4%
SCM
5
Stonepine Capital Management
Oregon
$18.2M +$5.79M +1,259,826 +47%
ACH
6
ArrowMark Colorado Holdings
Colorado
$11.8M +$1.27M +277,186 +12%
Holocene Advisors
7
Holocene Advisors
New York
$9.72M – – –
Massachusetts Financial Services
8
Massachusetts Financial Services
Massachusetts
$8.95M -$86.7K -18,866 -1%
Millennium Management
9
Millennium Management
New York
$8.89M -$4.18M -910,161 -32%
GIM
10
Granahan Investment Management
Massachusetts
$8.68M +$5.44M +1,183,731 +167%
BWLSA
11
Blue Water Life Science Advisors
California
$8.65M -$6.16M -1,340,000 -42%
FLAM
12
First Light Asset Management
Minnesota
$8.53M +$2.27M +493,344 +36%
State Street
13
State Street
Massachusetts
$8.32M +$83.8K +18,225 +1%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$8.24M +$530K +115,276 +7%
American Century Companies
15
American Century Companies
Missouri
$7.84M +$109K +23,670 +1%
PCM
16
Portolan Capital Management
Massachusetts
$7.57M +$4.73M +1,028,263 +165%
Morgan Stanley
17
Morgan Stanley
New York
$7.45M -$270K -58,852 -4%
Swedbank
18
Swedbank
Sweden
$7.34M – – –
RGI
19
River Global Investors
United Kingdom
$7.03M -$761K -165,605 -10%
GPGA
20
Grandeur Peak Global Advisors
Utah
$6.33M +$869K +189,064 +16%
Ameriprise
21
Ameriprise
Minnesota
$6.06M -$45.2K -9,826 -0.7%
SAM
22
Silvercrest Asset Management
New York
$5.8M +$798K +173,747 +16%
Artisan Partners
23
Artisan Partners
Wisconsin
$5.71M +$13.3K +2,897 +0.2%
MA
24
Mudita Advisors
United Kingdom
$3.81M +$767K +167,005 +25%
Northern Trust
25
Northern Trust
Illinois
$3.57M +$79.4K +17,286 +2%
1
2 3 4 5

MXCT Hedge Fund Activity: Q2 2023 in Review

116 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2023, worth a combined $303M — down 38% from $489M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MXCT positions and 10 closed out — a net gain of 2 holders — while 48 added to existing stakes and 36 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $5.79M. The largest seller was BAMCO Inc, exiting entirely with an estimated $9.84M sold.

  • 116 institutional investors held MaxCyte (MXCT) as of Q2 2023, up from 114 in Q1 2023.
  • Funds reported $303M of MaxCyte stock for Q2 2023, down 38% quarter-over-quarter.
  • 12 funds opened new MaxCyte positions in Q2 2023 and 10 closed out, a net change of +2 holders.
  • The largest MaxCyte buyer in Q2 2023 was Stonepine Capital Management, an estimated $5.79M added.
  • The largest MaxCyte seller in Q2 2023 was BAMCO Inc, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2023.